Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Lung Neoplasms × tremelimumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Non Small Cell Lung Cancer NSCLC 1 Lung Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

selpercatinib 2 tremelimumab 1 repotrectinib 1 pralsetinib 1 encorafenib 1 durvalumab 1 ceritinib 1 capmatinib 1 brigatinib 1 binimetinib 1 Pemetrexed 1 Crizotinib 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03703297 2025-11-21

ADRIATIC

AstraZeneca

Phase 3 Active not recruiting

730 enrolled 19 charts 1 FDA

Carcinoma, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡